— Know what they know.
Not Investment Advice
Also trades as: 0R1B.L (LSE) · $vol 0M · IDP.DE (XETRA) · $vol 0M · BIIB.SW (SIX)

BIIB Dividends

Biogen Inc.
1W: +4.0% 1M: +10.5% 3M: +20.8% YTD: +42.1% 1Y: +68.6% 3Y: -1.8% 5Y: -5.7%
$252.73
+0.47 (+0.19%)
 
Weekly Expected Move ±4.4%
$229 $240 $251 $262 $273
NASDAQ · Healthcare · Drug Manufacturers - General · Tech Score Strong Buy · Power 71 · $37.3B mcap · 147M float · 0.788% daily turnover · Short 70% of daily vol
Credit Risk of going bust: lower than 68% of companies Debt: 18.3% of company value Bonds: $137.0M held by 192 funds, 91 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $4.22 (down 98%), Biogen Inc. would be worth roughly what it owes.
Total debt $8.36B against a stock market value of $37.34B.
Distance to default 7.34 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.45B (short-term plus half of long-term), stock volatility 33.9%; Altman Z 3.16. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
BIIB does not currently pay a dividend.
This company has no dividend payment history on record.
Stock Split History (2 splits)
DateRatioType
2001-01-18 3:1 stock-split
1999-12-21 2:1 stock-split

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms